Endocrine oncology

Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study

Eur Thyroid JPublished Retrospective cohort study

Main finding · PTC-specific mortalityResult — go to the resultAdjusted hazard ratio 0.13 95% CI 0.04–0.46

Authors' conclusion

Incidental detection is associated with a lower risk of PTC-specific and competing mortality. Under the context of increasing magnitude of overdiagnosis, incorporation of detection route in clinical decision-making might be helpful to identify patients who might benefit from more extensive or conservative therapeutic strategies.

Study context

Population
Papillary thyroid cancer (PTC) patients at a cancer center in Guangzhou, baseline 2010–2018
Participants
2,874 patients
Exposure
Incidental vs non-incidental detection
  • Incidentaln = 2,011
Outcome
PTC-specific and competing mortality
Methodological detailshospital-based, single cancer center
  • Hospital-based
  • Single cancer center

Main finding

PTC-specific mortality · 5 years

Adjusted hazard ratio

0.13

95% CI 0.04–0.46

P = 0.01

By group

Incidentalvs Non-incidental
adjusted HR 0.13 (95% CI 0.04–0.46); P = 0.01

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeIncidentalNon-incidentalAdjusted HR (95% CI)P value
Competing mortality · 5 years0.4%1.4%0.47 (0.20–1.10)P = 0.10

Proportion incidentally detected

Detected incidentally, overall
70.0%
Incidental proportion 2011 to 2018
36.9% to 82.3%

Original publication

Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study. Eur Thyroid J. Published 6 November 2023. doi:10.1530/etj-23-0127

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.